相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Yaron Rotman et al.
GUT (2014)
Immune Responses to HCV and Other Hepatitis Viruses
Su-Hyung Park et al.
IMMUNITY (2014)
Reduction of HBV replication prolongs the early immunological response to IFNα therapy
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2014)
Restoration of HCV-specific CD8+T cell function by interferon-free therapy
Bianca Martin et al.
JOURNAL OF HEPATOLOGY (2014)
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
Lena Allweiss et al.
JOURNAL OF HEPATOLOGY (2014)
Therapy of Hepatitis C - Back to the Future
T. Jake Liang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Circulating Chemokine (C-X-C Motif) Receptor 5+CD4+ T Cells Benefit Hepatitis B e Antigen Seroconversion Through IL-21 in Patients With Chronic Hepatitis B Virus Infection
Yongyin Li et al.
HEPATOLOGY (2013)
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs
Denis Ouzan et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Lorenzo Micco et al.
JOURNAL OF HEPATOLOGY (2013)
Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
Julia Dietz et al.
JOURNAL OF VIROLOGY (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Jianhua Li et al.
NATURE IMMUNOLOGY (2013)
Current and Future Therapies for Hepatitis C Virus Infection
T. Jake Liang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
Michael J. Fuller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
Anna Schurich et al.
PLOS PATHOGENS (2013)
Combination of DNA Prime - Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
Anna D. Kosinska et al.
PLOS PATHOGENS (2013)
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
Fei Liu et al.
PLOS PATHOGENS (2013)
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
Markus H. Heim
NATURE REVIEWS IMMUNOLOGY (2013)
IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing
Francesca Spadaro et al.
BLOOD (2012)
Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?
Jordan J. Feld
GASTROENTEROLOGY (2012)
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2012)
Interferon-γ-Stimulated Genes, but Not USP18, Are Expressed in Livers of Patients With Acute Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2012)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients
Birgit Edlich et al.
HEPATOLOGY (2012)
Transcriptomic analysis of the woodchuck model of chronic hepatitis B
Simon P. Fletcher et al.
HEPATOLOGY (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis
Amalia Penna et al.
JOURNAL OF HEPATOLOGY (2012)
TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
Cheng Sun et al.
PLOS PATHOGENS (2012)
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B
Yu Chen et al.
ANTIVIRAL RESEARCH (2011)
Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2011)
Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice
Marc Luetgehetmann et al.
GASTROENTEROLOGY (2011)
Ribavirin Potentiates Interferon Action by Augmenting Interferon-Stimulated Gene Induction in Hepatitis C Virus Cell Culture Models
Emmanuel Thomas et al.
HEPATOLOGY (2011)
Tenofovir Selectively Regulates Production of Inflammatory CytokinesandShifts the IL-12/IL-10 Balance in Human Primary Cells
Jesper Melchjorsen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Circulating Tregs Correlate with Viral Load Reduction in Chronic HBV-Treated Patients with Tenofovir Disoproxil Fumarate
Nirupma TrehanPati et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir
Bart Takkenberg et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
Eric T. T. L. Tjwa et al.
JOURNAL OF HEPATOLOGY (2011)
Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy
Ivana Carey et al.
JOURNAL OF VIROLOGY (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Innate and Adaptive Immune Responses in Hepatitis B Virus Infection
Abhishek Das et al.
DIGESTIVE DISEASES (2010)
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2010)
Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling
Jordan J. Feld et al.
GASTROENTEROLOGY (2010)
Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients
Karsten Wursthorn et al.
HEPATOLOGY (2010)
Type I interferon: friend or foe?
Giorgio Trinchieri
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B Virus Replication Could Enhance Regulatory T Cell Activity by Producing Soluble Heat Shock Protein 60 From Hepatocytes
Yasuteru Kondo et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Chunxiao Xu et al.
JOURNAL OF VIROLOGY (2010)
Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment
Ji-Yuan Zhang et al.
PLOS ONE (2010)
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
Dimitra Peppa et al.
PLOS PATHOGENS (2010)
A randomized controlled trial of pegylated interferon-alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
Paola Piccolo et al.
ANTIVIRAL THERAPY (2009)
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Fabien Zoulim et al.
GASTROENTEROLOGY (2009)
Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Claire Dunn et al.
GASTROENTEROLOGY (2009)
Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections
Barbara Oliviero et al.
GASTROENTEROLOGY (2009)
Occult Hepatitis C: How Convincing Are the Current Data?
Martin-Walter Welker et al.
HEPATOLOGY (2009)
Reactivation of Hepatitis B
Jay H. Hoofnagle
HEPATOLOGY (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
Magdalena Sarasin-Filipowicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion
Alexander Evans et al.
HEPATOLOGY (2008)
Cutting edge: Programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: Race-dependent differences
Lucy Golden-Mason et al.
JOURNAL OF IMMUNOLOGY (2008)
High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection
Alleluiah Rutebemberwa et al.
JOURNAL OF IMMUNOLOGY (2008)
Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells
Gamal Badr et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4(+) T-cell reactivity
Helen Cooksley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy:: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
Pierre Vandepapeliere et al.
VACCINE (2007)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
Massimo Pilli et al.
GASTROENTEROLOGY (2007)
High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells
Takuya Miyagi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B
Jeroen N. Stoop et al.
VIROLOGY (2007)
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients
Andrea De Maria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Inhibition of alpha interferon signaling by hepatitis B virus
Verena Christen et al.
JOURNAL OF VIROLOGY (2007)
Virus-induced type IIFN stimulates generation of immunoproteasomes at the site of infection
Eui-Cheol Shin et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV
Renate G. van der Molen et al.
HEPATOLOGY (2006)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
MJ Walsh et al.
GUT (2006)
Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy
KH Tang et al.
JOURNAL OF HEPATOLOGY (2005)
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity
EI Rigopoulou et al.
HEPATOLOGY (2005)
Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy
GM Lauer et al.
JOURNAL OF VIROLOGY (2005)
Stealth and cunning: Hepatitis B and hepatitis C viruses
SF Wieland et al.
JOURNAL OF VIROLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection
O Franzese et al.
JOURNAL OF VIROLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antiviral action of ribavirin in chronic hepatitis C
JM Pawlotsky et al.
GASTROENTEROLOGY (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
F Rahman et al.
HEPATOLOGY (2004)
HCV persistence and immune evasion in the absence of memory T cell help
A Grakoui et al.
SCIENCE (2003)
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
C Boni et al.
JOURNAL OF HEPATOLOGY (2003)
Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection
NH Shoukry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon
E Herrmann et al.
HEPATOLOGY (2003)
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease
E Foy et al.
SCIENCE (2003)
Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells
YH Zhang et al.
JOURNAL OF VIROLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection
E Barnes et al.
HEPATOLOGY (2002)
Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures
V Pasquetto et al.
JOURNAL OF VIROLOGY (2002)
Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1α) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1β) production
Z Zidek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
C Boni et al.
HEPATOLOGY (2001)
Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: Detection by suppression-subtractive hybridization
R Patzwahl et al.
JOURNAL OF VIROLOGY (2001)
Peginterferon alfa-2a in patients with chronic hepatitis C
S Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
A Takaki et al.
NATURE MEDICINE (2000)
分享论文
